GAM
CRL icon

Groupama Asset Management’s Charles River Laboratories CRL Stock Holding History

Groupama Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480K Hold
2,121
– – 0.01% 321
2026
Q1 		$366K Sell
2,121
-284
-12% -$52.7K 0.01% 337
2025
Q4 		$480K Sell
2,405
-251
-9% -$45.5K 0.01% 341
2025
Q3 		$416K Buy
+2,656
New +$422K 0.01% 381
2025
Q2 		– Sell
-3,198
Closed -$497K – 396
2025
Q1 		$497K Sell
3,198
-218
-6% -$36.5K 0.01% 343
2024
Q4 		$627K Buy
3,416
+2,079
+155% +$400K 0.01% 318
2024
Q3 		$211K Buy
1,337
+24
+2% +$4.99K 0.01% 399
2024
Q2 		$271K Buy
1,313
+553
+73% +$125K ﹤0.01% 404
2024
Q1 		$396K Sell
760
-1,162
-60% -$277K 0.01% 405
2023
Q4 		$455K Buy
+1,922
New +$378K 0.01% 345

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Groupama Asset Management's CRL Position: Q2 2026 in Review

Groupama Asset Management held its Charles River Laboratories (CRL) position steady in Q2 2026 at 2,121 shares worth $480K. The position accounts for 0.01% of the portfolio, ranked #321.

Groupama Asset Management first reported a position in CRL in Q4 2023 and has held it in 10 quarters since. The position peaked at $627K in Q4 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Groupama Asset Management held 2,121 shares of Charles River Laboratories worth $480K as of Q2 2026.
  • Groupama Asset Management left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up 0.01% of Groupama Asset Management's portfolio in Q2 2026, its #321 holding.
  • Groupama Asset Management first reported a position in Charles River Laboratories in Q4 2023 and has held it in 10 quarters since.
  • Groupama Asset Management's Charles River Laboratories position peaked at $627K in Q4 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.